TAVI: clinical outcomes with new devices and delivery systems

Session comprising selected PCR London Valves 2019 abstract submissions

Chairpersons: J. Cavalcante, J. Popma, T. Walther

Speakers: G. Fontana, M. Nicotera, R.S. Rao, T. Vahl, N. Van Mieghem, J. Webb

Summary

Consult this session on TAVI to learn more about the clinical outcomes with new devices and delivery systems, such as the self-expandable Portico valve, the Portico IDE FlexNav delivery system, the SAPIEN 3 Ultra system, and more!

Presentations available when logged in:

The feasibility and safety of a balloon-expandable transcatheter heart valve: MyVal-1 study
A prospective multicentre study of the SAPIEN 3 Ultra system in intermediate-risk patients with severe aortic stenosis
First mid-/long-term follow-up results in patients undergoing TAVR with the self-expandable Portico valve for severe aortic stenosis: a real-world...
New TAVR technologies for patients with severe aortic stenosis and risk for coronary occlusion
RESPOND post-market study: three-year outcomes following TAVI with a repositionable and fully retrievable aortic valve
Safety outcomes from the Portico IDE FlexNav delivery system study of 100 high and extreme risk patients

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

TAVI: clinical outcomes with new devices and delivery systems

Session comprising selected PCR London Valves 2019 abstract submissions

Log in or create account for free